WANG Yong-Jun, XIONG Yun-Yun, YANG Jia-Lei, LI Guang-Shuo,YAN Ran, WANG Wen-Jie, WENG Jia-Xu, SHANGGUAN Yi. Highlights on Stroke Research in 2020[J]. Chinese Journal of Stroke, 2021, 16(02): 101-118.
[1] VOS T,LIM S S,ABBAFATI C,et al. Globalburden of 369 diseases and injuries in 204 countriesand territories,1990–2019:a systematic analysis forthe Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222.[2] PHAN T G,HASEEB A,BEARE R,et al. Googlingthe lifetime risk of stroke around the world[J/OL].F11:729[2021-02-01]. https://doi.org/10.3389/f rontNeurol,2020,neur.2020.00729.[3] KRISHNAMURTHI R V,IKEDA T,FEIGIN VL. Global,regional and country-specific burdenof ischaemic stroke,intracerebral haemorrhageand subarachnoid haemorrhage:a systematicanalysis of the global burden of disease study 2017[J].Neuroepidemiology,2020,54(2):171-179.[4] WANG Y J,LI Z X,GU H Q,et al. China strokestatistics 2019:a report from the national centerfor healthcare quality management in neurologicaldiseases,China National Clinical Research Center forNeurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicableDisease Control and Prevention,Chinese Center forDisease Control and Prevention and Institute for GlobalNeuroscience and Stroke Collaborations[J]. StrokeVasc Neurol,2020,5(3):211-239.[5] ILIFF J J,WANG M,LIAO Y,et al. A paravascularpathway facilitates CSF flow through the brainparenchyma and the clearance of interstitial solutes,including amyloid β[J/OL]. Sci Transl Med,2012,4(147):147ra111[2021-02-01]. https://doi.org/10.1126/scitranslmed.3003748.[6] LOUVEAU A,SMIRNOV I,KEYES T J,et al.Structural and functional features of central nervoussystem lymphatic vessels[J]. Nature,2015,523(7560):337-341.[7] MESTRE H,DU T,SWEENEY A M,et al.Cerebrospinal fluid influx drives acute ischemictissue swelling[J/OL]. Science,2020,367(6483):eaax7171[2021-02-01]. https://doi.org/10.1126/science.aax7171.[8] DHAR R. Automated quantitative assessmentof cerebral edema after ischemic stroke usingCSF volumetrics[J/OL]. Neurosci Lett,2020,724:134879[2021-02-01]. https://doi.org/10.1016/j.neulet.2020.134879.[9] DHAR R,CHEN Y,HAMZEHLOO A,et al.Reduction in cerebrospinal fluid volume as an earlyquantitative biomarker of cerebral edema afterischemic stroke[J]. Stroke,2020,51(2):462-467.[10] NAGANAWA S,TAOKA T. The glymphatic system:areview of the challenges in visualizing its structure andfunction with MR imaging[J/OL]. Magn Reson MedSci,2020[2021-02-01]. https://doi.org/10.2463/mrms.rev.2020-0122.[11] LANGHORNE P,AUDEBERT H J,CADILHAC D A,et al. Stroke systems of care in high-income countries:what is optimal?[J]. Lancet,2020,396(10260):1433-1442.[12] PANDIAN J D,KALKONDE Y,SEBASTIAN I A,etal. Stroke systems of care in low-income and middleincomecountries:challenges and opportunities[J].Lancet,2020,396(10260):1443-1451.[13] MARTINS S O,MONT'ALVERNE F,REBELLO LC,et al. Thrombectomy for stroke in the public health care system of brazil[J]. N Engl J Med,2020,382(24):2316-2326.[14] YANG P F,ZHANG Y W,ZHANG L,et al.Endovascular thrombectomy with or withoutintravenous alteplase in acute stroke[J]. N Engl JMed,2020,382(21):1981-1993.[15] WANG Y T,WU X,ZHU C C,et al. Bridgingthrombolysis achieved better outcomes than directthrombectomy after large vessel occlusion:anupdated meta-analysis[J]. Stroke,2021,52(1):356-365.[16] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Tenecteplase versus alteplase beforethrombectomy for ischemic stroke[J]. N Engl J Med,2018,378(17):1573-1582.[17] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Effect of intravenous tenecteplase doseon cerebral reperfusion before thrombectomy inpatients with large vessel occlusion ischemic stroke:the EXTEND-IA TNK part 2 randomized clinicaltrial[J]. JAMA,2020,323(13):1257-1265.[18] THOMALLA G,BOUTITIE F,MA H,et al.Intravenous alteplase for stroke with unknown timeof onset guided by advanced imaging:systematicreview and meta-analysis of individual patientdata[J]. Lancet,2020,396(10262):1574-1584.[19] HILL M D,GOYAL M,MENON B K,et al.Efficacy and safety of nerinetide for the treatmentof acute ischaemic stroke(ESCAPE-NA1):amulticentre,double-blind,randomised controlledtrial[J]. Lancet,2020,395(10227):878-887.[20] TARIQ S,SAH R G,CHAN L,et al. Recanalizationfollowing endovascular treatment and imagingof perfusion,regional infarction and atrophy tounderstand stroke evolution-NA1(REPERFUSENA1)[J]. Int J Stroke,2020,15(3):343-349.[21] WANG Y J,WANG Y L,ZHAO X Q,et al.Clopidogrel with aspirin in acute minor stroke ortransient ischemic attack[J]. N Engl J Med,2013,369(1):11-19.[22] JOHNSTON S C,AMARENCO P,DENISON H,etal. Ticagrelor and aspirin or aspirin alone in acuteischemic stroke or TIA[J]. N Engl J Med,2020,383(3):207-217.[23] DING L L,LIU C,LI Z X,et al. Incorporatingartificial intelligence into stroke care and research[J/OL]. Stroke,2020,51(12):e351-e354[2021-02-01].https://doi.org/10.1161/strokeaha.120.031295.[24] RIVERA S C,LIU X,CHAN A W,et al. Guidelinesfor clinical trial protocols for interventions involvingartificial intelligence:the SPIRIT-AI extension[J].Nat Med,2020,26(9):1351-1363.[25] LIU X,CRUZ RIVERA S,MOHER D,et al.Reporting guidelines for clinical trial reports forinterventions involving artificial intelligence:theCONSORT-AI extension[J]. Nat Med,2020,26(9):1364-1374.[26] 熊云云,李子孝,丁玲玲,等. 基于人工智能干预措施的临床试验方案指南:SPIRIT-AI扩展[J]. 中国卒中杂志,2020,15(11):1228-1238.[27] 李子孝,熊云云,丁玲玲,等. 人工智能干预性临床试验报告指南:CONSORT-AI扩展[J]. 中国卒中杂志,2020,15(12):1327-1336.[28] KANSAGRA A P,GOYAL M S,HAMILTON S,etal. Collateral effect of Covid-19 on stroke evaluationin the United States[J]. N Engl J Med,2020,383(4):400-401.[29] ZHOU Y F,HONG C D,CHANG J,et al.Intravenous thrombolysis for acute ischaemic strokeduring COVID-19 pandemic in Wuhan,China:amulticentre,retrospective cohort study[J]. J NeurolNeurosurg Psychiatry,2021,92(2):226-228.[30] KERLEROUX B,FABACHER T,BRICOUT N,etal. Mechanical thrombectomy for acute ischemicstroke amid the COVID-19 outbreak:decreasedactivity,and increased care delays[J]. Stroke,2020,51(7):2012-2017.[31] AHA/ASA Stroke Council Leadership. Temporaryemergency guidance to US stroke centers during thecoronavirus disease 2019(COVID-19)pandemic:onbehalf of the American Heart Association/AmericanStroke Association Stroke Council Leadership[J].Stroke,2020,51(6):1910-1912.[32] TSIVGOULIS G,KATSANOS A H,ORNELLOR,et al. Ischemic stroke epidemiology during theCOVID-19 pandemic:navigating uncharted waterswith changing tides[J]. Stroke,2020,51(7):1924-1926.[33] LEE M H,PERL D P,NAIR G,et al. Microvascularinjury in the brains of patients with Covid-19[J]. NEngl J Med,2021,384(5):481-483.[34] IADECOLA C,ANRATHER J,KAMEL H. Effectsof COVID-19 on the nervous system[J]. Cell,2020,183(1):16-27.[35] KASHYAP V S,SCHNEIDER P A,FOTEH M,etal. Early outcomes in the ROADSTER 2 study oftranscarotid artery revascularization in patients withsignificant carotid artery disease[J]. Stroke,2020,51(9):2620-2629.